OTCMKTS:GSTC GlobeStar Therapeutics (GSTC) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsShort InterestBuy This Stock About GlobeStar Therapeutics Stock (OTCMKTS:GSTC) 30 days 90 days 365 days Advanced Chart Get GlobeStar Therapeutics alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage Volume3.11 million shsMarket Capitalization$124 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewGlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. It offers Amethyst, a compound intended to treat neurodegeneration. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. GlobeStar Therapeutics Corporation is based in Richland, Washington.Read More… Receive GSTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GlobeStar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address GSTC Stock News HeadlinesGlobeStar Therapeutics Corporat (GSTC) stock forecast and price targetJanuary 23, 2025 | finance.yahoo.comCompare with GlobeStar Therapeutics Corp (GSTC)May 29, 2024 | msn.comTrump’s Strange “Midnight Tweet” Could Trigger Massive GainsPresident Trump sends out explosive tweets at all hours of the day... And the market reacts violently. According to one Wall Street legend, Americans can target as much as 627% within HOURS. You have to see how to target these massive profits (from Trump’s latest tweets) for yourself....June 6, 2025 | Monument Traders Alliance (Ad)GlobeStar Therapeutics Corporation: Globestar Therapeutics Update on Project Amethyst and Recent FinancialsMarch 28, 2024 | finanznachrichten.deKHTRF Knight Therapeutics Inc.December 20, 2023 | seekingalpha.comGlobeStar Therapeutics Corp GSTCDecember 14, 2023 | morningstar.comGlobeStar signs deal with Advanced Innovative to develop clinical studies for MS treatmentNovember 4, 2023 | msn.comGlobeStar Therapeutics Enters Into Definitive Agreement With Advanced Innovative Partners To Develop Clinical Studies and Strategies for Multiple Sclerosis TreatmentNovember 2, 2023 | finance.yahoo.comSee More Headlines GSTC Stock Analysis - Frequently Asked Questions How do I buy shares of GlobeStar Therapeutics? Shares of GSTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of GlobeStar Therapeutics own? Based on aggregate information from My MarketBeat watchlists, some other companies that GlobeStar Therapeutics investors own include Arrival (ARVL), Cosmos Health (COSM), COMSovereign (COMS), Good Hemp (GHMP), Meta Materials (MMTLP), Palisade Bio (PALI) and Sintx Technologies (SINT). Company Calendar Today6/06/2025Fiscal Year End9/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolOTCMKTS:GSTC CIK1502152 Webangiosoma.com Phone(206) 451-1970FaxN/AEmployees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$1.95 million Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-3,176.19% Debt Debt-to-Equity RatioN/A Current Ratio0.05 Quick Ratio0.05 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares1,241,106,000Free Float1,210,078,000Market Cap$124,000.00 OptionableNot Optionable Beta1.95 Elon Musk's Next MoveExplore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.Get This Free Report This page (OTCMKTS:GSTC) was last updated on 6/6/2025 by MarketBeat.com Staff From Our PartnersThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Wealth Reset: Could You Be The First Beneficiary?Trump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredA new rule goes live in July — and the banks are quietly cashing inA major shift is coming this July — and Wall Street isn't waiting around. Thanks to a new rule going into e...American Alternative | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredHow to target 627% gains from Trump’s tweetsPresident Trump is shaking up the market with his tweets and Truth Social posts... But while this chaos has...Monument Traders Alliance | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GlobeStar Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share GlobeStar Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GSTC Stock Free GSTC Stock Alerts